Unity Biotechnology, Inc.UBXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank25
3Y CAGR-12.5%
5Y CAGR-5.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-12.5%/yr
vs +24.4%/yr prior
5Y CAGR
-5.1%/yr
Recent deceleration
Acceleration
-36.9pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $15.46M | -17.6% |
| 2023 | $18.77M | -10.4% |
| 2022 | $20.95M | -9.1% |
| 2021 | $23.06M | -4.0% |
| 2020 | $24.02M | +19.8% |
| 2019 | $20.05M | +25.2% |
| 2018 | $16.02M | +66.5% |
| 2017 | $9.62M | +87.2% |
| 2016 | $5.14M | - |